In the first ruling of its kind, a federal appeals court upheld a $142 million jury verdict against drug maker Pfizer for fraudulent marketing based on statistical evidence that its marketing campaign caused doctors to prescribe epilepsy drug Neurontin for unapproved uses. The ruling was one of a set of three decisions the 1st U.S. ...
Trending Articles
More Pages to Explore .....